EP 2313393 A1 20110427 - AZETIDINE POLYSUBSTITUTED COMPOUNDS, PREPARATION THEREOF, AND THERAPEUTIC APPLICATION THEREOF
Title (en)
AZETIDINE POLYSUBSTITUTED COMPOUNDS, PREPARATION THEREOF, AND THERAPEUTIC APPLICATION THEREOF
Title (de)
POLYSUBSTITUIERTE AZETIDINVERBINDUNGEN, DEREN HERSTELLUNG UND DEREN THERAPEUTISCHE VERWENDUNG
Title (fr)
COMPOSES D'AZÉTIDINES POLYSUBSTITUES, LEUR PRÉPARATION ET LEUR APPLICATION EN THÉRAPEUTIQUE
Publication
Application
Priority
- FR 2009001003 W 20090813
- FR 0804595 A 20080814
Abstract (en)
[origin: WO2010018328A1] The invention relates to compounds of the formula (I) where: R is a (C1-C6)alkyl group, a halo(C1-C6)alkyl group; R1 is a hydrogen atom; R2 is a heteroaromatic group or a heteroaromatic(C1-C4)alkyl group, said groups being optionally substituted; R3 and R4 represent independently from each other an optionally substituted phenyl group; Y is a hydrogen atom, a halogen, a cyano, a (C1-C6)alkyl group, a halo(C1-C6)alkyl group, a (C1-C6)alkoxy group, a halo(C1-C6)alkoxy group or a (C1-C6)alkylS(0)p group; and p is 0 to 2. Said compounds can be in the form of a base or a salt for addition to an acid. The invention also relates to a method for preparing same and to the therapeutic application thereof.
IPC 8 full level
C07D 401/12 (2006.01); A61K 31/40 (2006.01); A61P 1/00 (2006.01); A61P 11/00 (2006.01); A61P 25/00 (2006.01); C07D 403/12 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01)
CPC (source: EP KR US)
A61K 31/427 (2013.01 - KR); A61P 1/00 (2017.12 - EP); A61P 1/04 (2017.12 - EP); A61P 1/08 (2017.12 - EP); A61P 1/10 (2017.12 - EP); A61P 1/12 (2017.12 - EP); A61P 1/16 (2017.12 - EP); A61P 3/00 (2017.12 - EP); A61P 3/04 (2017.12 - EP); A61P 3/06 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 5/00 (2017.12 - EP); A61P 7/00 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 13/02 (2017.12 - EP); A61P 13/10 (2017.12 - EP); A61P 15/00 (2017.12 - EP); A61P 19/00 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 19/10 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/04 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/18 (2017.12 - EP); A61P 25/20 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 25/30 (2017.12 - EP); A61P 25/34 (2017.12 - EP); A61P 27/06 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/00 (2017.12 - EP); A61P 31/04 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 37/00 (2017.12 - EP); A61P 37/02 (2017.12 - EP); A61P 37/06 (2017.12 - EP); C07D 401/12 (2013.01 - EP US); C07D 403/12 (2013.01 - EP US); C07D 413/12 (2013.01 - EP US); C07D 417/10 (2013.01 - KR); C07D 417/12 (2013.01 - EP KR US)
Citation (search report)
See references of WO 2010018328A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
Designated extension state (EPC)
AL BA RS
DOCDB simple family (publication)
WO 2010018328 A1 20100218; AR 073043 A1 20101006; AU 2009281057 A1 20100218; BR PI0917464 A2 20151201; CA 2733397 A1 20100218; CN 102186839 A 20110914; EP 2313393 A1 20110427; FR 2934995 A1 20100219; FR 2934995 B1 20100827; IL 211210 A0 20110428; JP 2011530575 A 20111222; KR 20110044782 A 20110429; MX 2011001678 A 20110405; RU 2011109180 A 20120920; TW 201011019 A 20100316; US 2011152236 A1 20110623; UY 32051 A 20100326
DOCDB simple family (application)
FR 2009001003 W 20090813; AR P090103131 A 20090813; AU 2009281057 A 20090813; BR PI0917464 A 20090813; CA 2733397 A 20090813; CN 200980140820 A 20090813; EP 09737012 A 20090813; FR 0804595 A 20080814; IL 21121011 A 20110213; JP 2011522538 A 20090813; KR 20117005735 A 20090813; MX 2011001678 A 20090813; RU 2011109180 A 20090813; TW 98127313 A 20090813; US 200913058913 A 20090813; UY 32051 A 20090814